Medical Specialties Industry Financials, Performance and Ratios
-
Industry Score
38.0 /100
Rank 68 out of 131 Industries -
Advance/Decline
146/53
-
No. of Companies199
-
Avg. Market Cap8,465
-
Price to Earning Ratio33.65
-
Price to Earning Growth Ratio3.47
-
Price to Book Ratio5.90
-
Return on Equity14.30
-
Return on Capital Employed-
-
Return on Assets8.36
-
Dividend yield 1 year %0.28 %
-
Net Profit Growth Annual YoY %-13.16 %
-
Net Profit Growth Qtr YoY %-1.47 %
-
Net Profit Growth Qtr QoQ %-22.22 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Medical Specialties Industry Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Medical Specialties Peer comparison
Compare all stocks in Medical Specialties industry listed on stock exchanges
| Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Agilent Tech |
|
38,413.6
|
136.0
|
L
 0.4%
H
135.0
137.5
|
L
 7.0%
H
125.6
138.6
|
L
 18.2%
H
115.0
141.1
|
L
 19.9%
H
108.4
141.1
|
L
 13.9%
H
108.4
160.3
|
L
 14.9%
H
96.4
160.3
|
L
 -7.7%
H
96.4
179.6
|
L
 208.3%
H
42.0
179.6
|
| Abbott |
|
163,939.5
|
94.1
|
L
 0.9%
H
93.2
95.2
|
L
 6.5%
H
87.2
95.2
|
L
 8.6%
H
85.0
95.2
|
L
 -10.0%
H
82.0
105.5
|
L
 -29.6%
H
82.0
137.5
|
L
 -13.3%
H
82.0
141.2
|
L
 -16.5%
H
82.0
142.6
|
L
 148.3%
H
36.8
142.6
|
| Alcon Inc - Registered Shares |
|
33,066.1
|
67.8
|
L
 -0.5%
H
67.4
68.5
|
L
 4.8%
H
64.9
69.3
|
L
 0.2%
H
63.8
69.3
|
L
 -9.0%
H
61.8
82.4
|
L
 -22.2%
H
61.8
92.6
|
L
 -15.6%
H
61.8
101.1
|
L
 -3.9%
H
55.2
101.1
|
L
H
39.4
101.1
|
| Artivion Inc |
|
1,146.1
|
23.6
|
L
 4.2%
H
22.5
24.0
|
L
 11.4%
H
20.1
24.0
|
L
 1.8%
H
19.8
24.0
|
L
 -35.1%
H
19.2
39.7
|
L
 -22.9%
H
19.2
48.3
|
L
 50%
H
12.2
48.3
|
L
 -19.1%
H
9.6
48.3
|
L
 104.4%
H
9.6
48.3
|
| Avanos Medical Inc |
|
1,168.9
|
25.0
|
L
 0.2%
H
24.9
25.0
|
L
 0.0%
H
24.9
25.0
|
L
 0.8%
H
24.7
25.5
|
L
 80.1%
H
13.4
25.5
|
L
 105.0%
H
9.3
25.5
|
L
 -2.2%
H
9.3
26.6
|
L
 -35.7%
H
9.3
38.9
|
L
 -22.8%
H
9.3
73.0
|
| Baxter International |
|
11,383.0
|
22.0
|
L
 2.3%
H
21.4
22.2
|
L
 10.8%
H
19.4
22.2
|
L
 13.7%
H
18.1
22.2
|
L
 32.2%
H
15.7
22.2
|
L
 -27.7%
H
15.7
31.8
|
L
 -50.7%
H
15.7
50.2
|
L
 -73.2%
H
15.7
89.7
|
L
 -49.7%
H
15.7
95.2
|
| Becton, Dickinson and Co. |
|
42,962.3
|
155.9
|
L
 3%
H
151.6
156.9
|
L
 8.3%
H
140.1
156.9
|
L
 5.5%
H
140.1
156.9
|
L
 -0.9%
H
140.1
160.0
|
L
 -8.3%
H
140.1
213.1
|
L
 -39.2%
H
140.1
287.3
|
L
 -33.7%
H
140.1
287.3
|
L
 -4.1%
H
140.1
287.3
|
| Butterfly Network Inc (Class A) |
|
2,326.0
|
8.9
|
L
 10.9%
H
8.0
8.9
|
L
 -0.1%
H
6.8
8.9
|
L
 95.8%
H
4.4
8.9
|
L
 114.2%
H
3.7
8.9
|
L
 340.1%
H
1.3
8.9
|
L
 340.1%
H
0.7
8.9
|
L
 -38.1%
H
0.7
14.7
|
L
H
0.7
29.1
|
| Bio-Rad Laboratories Inc (Class A) |
|
8,049.6
|
300.8
|
L
 0.8%
H
293.5
305
|
L
 6.5%
H
270
305
|
L
 1.3%
H
270
319.9
|
L
 8.8%
H
236.7
319.9
|
L
 23.5%
H
236.7
343.1
|
L
 -17.7%
H
211.4
431.8
|
L
 -52.5%
H
211.4
832.7
|
L
 116.9%
H
135.9
832.7
|
| Bausch + Lomb Corp |
|
5,818.7
|
16.3
|
L
 2.6%
H
15.9
16.7
|
L
 9.8%
H
14.8
16.7
|
L
 3.4%
H
14.7
16.7
|
L
 2.7%
H
14.7
17.1
|
L
 35.2%
H
12.1
18.9
|
L
 -16.6%
H
10.5
22.0
|
L
H
10.5
22.0
|
L
H
10.5
22.0
|
| Conmed Corp |
|
1,082.4
|
36.0
|
L
 4.0%
H
34.8
36.0
|
L
 10.3%
H
31.4
36.0
|
L
 -0.3%
H
31.4
37.5
|
L
 -1.9%
H
31.4
40.6
|
L
 -31.3%
H
31.4
56.6
|
L
 -72.7%
H
31.4
138.3
|
L
 -74.5%
H
31.4
159.1
|
L
 -18.7%
H
31.4
159.1
|
| Cooper Companies |
|
13,851.1
|
71.0
|
L
 0.5%
H
69.3
72.2
|
L
 7.8%
H
65.0
72.2
|
L
 14.5%
H
59.1
72.2
|
L
 -0.7%
H
58.9
72.6
|
L
 1.9%
H
58.9
89.8
|
L
 -24.0%
H
58.9
112.4
|
L
 -28.3%
H
58.9
115.9
|
L
 70.3%
H
39.7
115.9
|
| Danaher |
|
138,857.5
|
196.2
|
L
 1.8%
H
192.3
196.2
|
L
 10.7%
H
175
197.6
|
L
 13.5%
H
171.6
197.6
|
L
 4.6%
H
160.9
200.5
|
L
 -2.5%
H
160.9
242.8
|
L
 -17.5%
H
160.9
281.7
|
L
 -26.4%
H
160.9
334.0
|
L
 163.6%
H
73.4
334.0
|
| Edwards Lifesciences |
|
52,271.1
|
90.8
|
L
 1.2%
H
89.3
92.5
|
L
 3.9%
H
85.3
92.5
|
L
 3.7%
H
83.2
92.5
|
L
 10.6%
H
76.5
92.5
|
L
 17.7%
H
72.3
92.5
|
L
 1.4%
H
58.9
96.1
|
L
 -12.3%
H
58.9
131.7
|
L
 183.6%
H
27.0
131.7
|
| Glaukos Corp |
|
8,482.4
|
144.4
|
L
 1.3%
H
140.9
145
|
L
 10.5%
H
128.5
145.4
|
L
 25.6%
H
99.5
145.4
|
L
 34.0%
H
99.5
148.1
|
L
 42.9%
H
73.2
148.1
|
L
 109.9%
H
59.2
163.7
|
L
 67.4%
H
33.3
163.7
|
L
 412.7%
H
23.1
163.7
|
| Globus Medical Inc (Class A) |
|
11,708.0
|
86.3
|
L
 1.9%
H
83.8
86.3
|
L
 8.9%
H
77.7
86.3
|
L
 1.4%
H
74.7
86.3
|
L
 -0.3%
H
74.5
97.4
|
L
 46.6%
H
51.8
101.4
|
L
 49.2%
H
43.4
101.4
|
L
 11.3%
H
43.4
101.4
|
L
 261.6%
H
19.3
101.4
|
| Haemonetics Corp |
|
3,512.5
|
77.3
|
L
 -0.4%
H
76.4
79.8
|
L
 4.2%
H
72.0
79.8
|
L
 15.6%
H
64.8
82.0
|
L
 39.2%
H
51
82.0
|
L
 3.4%
H
47.3
87.3
|
L
 -7.9%
H
47.3
98.0
|
L
 17.2%
H
43.5
98.0
|
L
 168.7%
H
28.2
142.1
|
| Inspire Medical Systems Inc |
|
1,317.3
|
45.7
|
L
 5.2%
H
42.8
46.0
|
L
 7.3%
H
40.0
46.0
|
L
 8.9%
H
38.9
46.0
|
L
 -9.4%
H
38.9
59.0
|
L
 -64.8%
H
38.9
147.0
|
L
 -85.3%
H
38.9
330
|
L
 -76.9%
H
38.9
330
|
L
H
22.5
330
|
| Integer Holdings Corp |
|
3,188.0
|
93.9
|
L
 0.8%
H
92.5
94.9
|
L
 3.2%
H
87.0
94.9
|
L
 4.2%
H
87.0
94.9
|
L
 8.1%
H
77.1
94.9
|
L
 -23.0%
H
62
123.8
|
L
 8.9%
H
62
146.4
|
L
 -0.3%
H
50.1
146.4
|
L
 210.3%
H
18.1
146.4
|
| Medtronic |
|
103,658.1
|
81.0
|
L
 1.5%
H
79.7
81.9
|
L
 2.1%
H
78.3
82.5
|
L
 4.4%
H
73.3
82.8
|
L
 -6.9%
H
73.3
88.8
|
L
 -5.3%
H
73.3
106.3
|
L
 -6.9%
H
68.9
106.3
|
L
 -35.2%
H
68.9
135.9
|
L
 -2.7%
H
68.9
135.9
|
| Mettler-Toledo International |
|
25,537.4
|
1,263.8
|
L
 1.6%
H
1240.6
1269.6
|
L
 10.4%
H
1132.7
1269.6
|
L
 14.8%
H
1089.4
1269.6
|
L
 -0.5%
H
1023.1
1365.8
|
L
 5.9%
H
1023.1
1525.2
|
L
 -1.3%
H
928.5
1546.9
|
L
 -6.5%
H
928.5
1714.8
|
L
 249.5%
H
343.6
1714.8
|
| Envista Holdings Corp |
|
4,387.1
|
27.0
|
L
 1.2%
H
26.4
27
|
L
 4.1%
H
25.2
27
|
L
 14.7%
H
22.4
27
|
L
 4.3%
H
22.4
29.5
|
L
 37.2%
H
18.8
30.4
|
L
 -20.1%
H
14.2
36.1
|
L
 -38.6%
H
14.2
52.0
|
L
H
10.1
52.0
|
| Owens & Minor Inc |
|
255.8
|
3.3
|
L
 5.4%
H
3.1
3.3
|
L
 3.4%
H
3.0
3.4
|
L
 21.0%
H
2.5
3.4
|
L
 59.1%
H
2.1
4.7
|
L
 -59.9%
H
1.8
9.6
|
L
 -82.1%
H
1.8
28.4
|
L
 -91.9%
H
1.8
49.1
|
L
 -91.0%
H
1.8
49.2
|
| Penumbra Inc |
|
12,453.5
|
316.6
|
L
 -0.2%
H
316.6
319.0
|
L
 -0.2%
H
315.0
319.0
|
L
 -3.5%
H
315.0
328.2
|
L
 -5.9%
H
315.0
337.4
|
L
 24.9%
H
221.3
362.4
|
L
 -3.8%
H
148
362.4
|
L
 11.8%
H
114.9
362.4
|
L
 444.5%
H
55.0
362.4
|
| Koninklijke Philips N.V. (ADR) |
|
26,340.7
|
27.1
|
L
 -0.7%
H
27.0
27.2
|
L
 1.2%
H
26.6
27.6
|
L
 0.6%
H
25.3
27.6
|
L
 -0.2%
H
25.1
30.0
|
L
 12.5%
H
23.8
33.4
|
L
 31.7%
H
17.8
33.4
|
L
 -46.4%
H
11.8
50.2
|
L
 13.7%
H
11.8
61.2
|
| Qiagen NV |
|
8,128.3
|
39.4
|
L
 1.2%
H
38.7
39.4
|
L
 6.7%
H
36.3
39.6
|
L
 10.9%
H
35.5
39.6
|
L
 -0.8%
H
32.5
42.3
|
L
 -22.1%
H
32.5
57.8
|
L
 -21.9%
H
32.5
57.8
|
L
 -27.3%
H
32.5
64.7
|
L
 61.8%
H
23.1
65.9
|
| ResMed |
|
29,053.3
|
200.3
|
L
 0.9%
H
198.2
201.9
|
L
 6.2%
H
187.2
202.7
|
L
 -3.7%
H
180.3
211.6
|
L
 -10.0%
H
180.3
234.9
|
L
 -21.8%
H
180.3
293.8
|
L
 -6.6%
H
132.2
293.8
|
L
 -18.1%
H
132.2
301.3
|
L
 230.9%
H
56.6
301.3
|
| Steris PLC |
|
21,018.7
|
215.7
|
L
 2.4%
H
212.0
216.4
|
L
 6.5%
H
198.9
216.4
|
L
 -0.3%
H
198.0
217.9
|
L
 -3.5%
H
195.1
227.9
|
L
 -9.6%
H
195.1
269.4
|
L
 1.7%
H
195.1
269.4
|
L
 4.3%
H
159.2
269.4
|
L
 229.6%
H
63.3
269.4
|
| Stevanato Grp Spa |
|
4,870.4
|
17.8
|
L
 -3.0%
H
17.4
18.7
|
L
 1.7%
H
16.5
18.7
|
L
 -0.7%
H
16.3
19.8
|
L
 31.0%
H
12.9
19.8
|
L
 -28.9%
H
12.9
28
|
L
 -43.5%
H
12.9
36.3
|
L
H
12.9
36.3
|
L
H
12.9
36.3
|
| Stryker |
|
127,548.0
|
332.7
|
L
 5.3%
H
317.8
333.8
|
L
 8.1%
H
303.5
333.8
|
L
 6.3%
H
291.0
333.8
|
L
 0.0%
H
281
352.8
|
L
 -14.8%
H
281
404.9
|
L
 12.1%
H
250.0
406.2
|
L
 26.5%
H
188.8
406.2
|
L
 185.4%
H
106.5
406.2
|
| Smith & Nephew PLC (ADR) |
|
12,692.4
|
30.0
|
L
 -0.6%
H
29.9
30.3
|
L
 -0.1%
H
29.4
30.6
|
L
 -1.3%
H
29.1
31.4
|
L
 -5.5%
H
29.1
34.7
|
L
 -0.6%
H
29.1
38.8
|
L
 -4.4%
H
21.5
38.8
|
L
 -31.4%
H
21.5
44.3
|
L
 -7.9%
H
21.5
52.3
|
| Teleflex Incorporated |
|
5,748.9
|
129.9
|
L
 1.6%
H
126.8
131.6
|
L
 2.3%
H
120.9
131.6
|
L
 -1.5%
H
120.9
136.6
|
L
 17.5%
H
113.4
139.7
|
L
 8.6%
H
100.2
139.7
|
L
 -45.8%
H
100.2
263.0
|
L
 -68.5%
H
100.2
428.4
|
L
 -24.2%
H
100.2
449.4
|
| Thermo Fisher |
|
190,653.0
|
513.0
|
L
 1.4%
H
499.6
514.8
|
L
 10.4%
H
458.9
516.0
|
L
 14.5%
H
447.4
516.0
|
L
 5.0%
H
435.3
538.4
|
L
 24.5%
H
401.5
644.0
|
L
 -1.7%
H
385.5
644.0
|
L
 4.1%
H
385.5
672.3
|
L
 253.0%
H
139.1
672.3
|
| Waters |
|
36,761.8
|
374.4
|
L
 -0.7%
H
369.4
379.7
|
L
 5.3%
H
353.5
380.6
|
L
 10.6%
H
339.7
385.3
|
L
 24.6%
H
287.2
385.3
|
L
 5.5%
H
275.1
414.2
|
L
 44.1%
H
231.9
423.6
|
L
 10.8%
H
231.9
428.2
|
L
 176.3%
H
131.4
428.2
|
| West Pharma Services |
|
24,786.7
|
350.9
|
L
 1.2%
H
342.7
351.4
|
L
 7.0%
H
324.7
352.3
|
L
 11.0%
H
308.2
352.3
|
L
 41.4%
H
240.2
352.3
|
L
 60.2%
H
206.8
352.3
|
L
 -3.9%
H
187.4
415.7
|
L
 -2.6%
H
187.4
475.4
|
L
 381.6%
H
70.2
475.4
|
| Zimmer Biomet Holdings |
|
18,011.4
|
93.1
|
L
 2.4%
H
91.0
93.3
|
L
 5.8%
H
87.1
93.3
|
L
 10.3%
H
81.6
93.3
|
L
 4.4%
H
79.1
97.8
|
L
 1.5%
H
79.1
108.3
|
L
 -34.8%
H
79.1
147.5
|
L
 -40.4%
H
79.1
156.3
|
L
 -15.2%
H
70.0
169.7
|
| BioRad Laboratories Inc |
|
8,535.7
|
296.5
|
L
H
292.0
296.5
|
L
 -2.5%
H
289.2
298.0
|
L
 10.9%
H
289.2
304.2
|
L
 10.4%
H
244.5
304.2
|
L
 18.6%
H
244.5
321.1
|
L
 -10.7%
H
225.3
373.4
|
L
 -10.7%
H
225.3
373.4
|
L
 -10.7%
H
225.3
373.4
|
| Revvity |
|
12,608.5
|
113.0
|
L
 -0.5%
H
111.6
116.2
|
L
 13.0%
H
97.4
116.2
|
L
 16.7%
H
95.7
116.2
|
L
 29.7%
H
81.2
116.2
|
L
 14.4%
H
81.2
118.3
|
L
 -3.2%
H
79.5
132.0
|
L
 -25.9%
H
79.5
203.2
|
L
 117.9%
H
45.4
203.2
|
| Aethlon Medical Inc |
|
2.1
|
0.9
|
L
 -2.3%
H
0.8
1.0
|
L
 -54.0%
H
0.8
1.8
|
L
 -64.5%
H
0.8
3.2
|
L
 -61.7%
H
0.8
3.2
|
L
 -95.5%
H
0.8
27.4
|
L
 -99.7%
H
0.8
400
|
L
 -100.0%
H
0.8
4976
|
L
 -100.0%
H
0.8
109078.8
|
| Ainos Inc |
|
12.7
|
1.7
|
L
 -3.9%
H
1.7
1.8
|
L
 -5.5%
H
1.7
2.0
|
L
 -45.3%
H
1.7
3.0
|
L
 25.4%
H
1.3
3.9
|
L
 -28.2%
H
1.3
4.5
|
L
 -90.0%
H
1.3
30.5
|
L
 -99.6%
H
1.3
525
|
L
 355.3%
H
0.1
1781.3
|
| Airsculpt Tech Inc |
|
322.4
|
4.6
|
L
 3.4%
H
4.4
4.6
|
L
 -7.5%
H
4.4
4.9
|
L
 -16.8%
H
4.4
5.8
|
L
 40.6%
H
2.3
5.8
|
L
 -3.6%
H
1.5
12
|
L
 -44.2%
H
1.5
12
|
L
H
1.5
18.5
|
L
H
1.5
18.5
|
| Align Tech |
|
12,778.8
|
178.4
|
L
 1.6%
H
174.0
179.4
|
L
 -2%
H
165.5
180.5
|
L
 9.1%
H
160.3
185
|
L
 0.6%
H
151.6
200.4
|
L
 -5.0%
H
122
208.3
|
L
 -46.2%
H
122
413.2
|
L
 -71.0%
H
122
737.5
|
L
 125.9%
H
77.1
737.5
|
| Angiodynamic Inc |
|
553.7
|
13.4
|
L
 -1.9%
H
13.3
13.8
|
L
 10.3%
H
12.1
13.8
|
L
 13.6%
H
10.9
13.8
|
L
 18.9%
H
9.4
13.8
|
L
 35.8%
H
8.4
14.0
|
L
 24.8%
H
5.3
14.0
|
L
 -52.0%
H
5.3
32
|
L
 -0.3%
H
5.3
32
|
| Anika Therapeutics Inc |
|
200.9
|
15.1
|
L
 3.3%
H
14.6
15.2
|
L
 4.7%
H
13.8
15.2
|
L
 1.4%
H
13.8
15.8
|
L
 2.4%
H
11.9
16.2
|
L
 39.4%
H
7.9
16.2
|
L
 -42.1%
H
7.9
29.1
|
L
 -66.5%
H
7.9
45.8
|
L
 -70.4%
H
7.9
75.7
|
| Apyx Medical Corp |
|
188.4
|
4.5
|
L
 7.9%
H
4.1
4.5
|
L
 9.5%
H
3.9
4.5
|
L
 10.0%
H
3.8
5.1
|
L
 17.2%
H
2.8
5.1
|
L
 100.9%
H
1.6
5.1
|
L
 -40.4%
H
0.8
8.0
|
L
 -56.8%
H
0.8
17.5
|
L
 157.1%
H
0.8
17.5
|
| Accuray Inc |
|
30.9
|
0.3
|
L
 -18.8%
H
0.3
0.3
|
L
 -25.7%
H
0.3
0.4
|
L
 -31.6%
H
0.3
0.4
|
L
 -31.6%
H
0.3
0.5
|
L
 -80.3%
H
0.3
2.1
|
L
 -93.1%
H
0.3
4.3
|
L
 -94.4%
H
0.3
5.9
|
L
 -94.8%
H
0.3
6.4
|
| Alphatec Holdings Inc |
|
1,430.2
|
9.3
|
L
 5.3%
H
8.8
9.3
|
L
 5.6%
H
8.1
9.3
|
L
 15.4%
H
7.3
9.3
|
L
 -19.3%
H
6.8
11.8
|
L
 -14.7%
H
6.8
23.3
|
L
 -47.4%
H
4.9
23.3
|
L
 -41.1%
H
4.9
23.3
|
L
 176.8%
H
1.2
23.3
|
| Atricure Inc |
|
1,528.3
|
30.2
|
L
 7.3%
H
28.3
30.4
|
L
 4.8%
H
27.6
30.4
|
L
 4.8%
H
25.4
30.4
|
L
 0.5%
H
25.4
30.5
|
L
 -8.2%
H
25.4
43.2
|
L
 -38.1%
H
18.9
59.6
|
L
 -62.4%
H
18.9
89.2
|
L
 108.7%
H
13.5
89.2
|
| Axogen Inc |
|
2,389.3
|
44.9
|
L
 1.0%
H
43.5
45.2
|
L
 0.2%
H
41.4
46
|
L
 8.4%
H
38.1
46
|
L
 39.3%
H
30
46
|
L
 329.1%
H
10.2
46
|
L
 400.9%
H
3.5
46
|
L
 103.5%
H
3.5
46
|
L
 622.3%
H
3.5
56.9
|
| Bone Biologics Corp |
|
2.5
|
1.4
|
L
 4.5%
H
1.3
1.4
|
L
 -4.1%
H
1.3
1.4
|
L
 11.1%
H
1.2
1.5
|
L
 25%
H
1.1
1.5
|
L
 -66.4%
H
1.1
6.2
|
L
 -98.1%
H
1.1
85.0
|
L
 -100.0%
H
1.1
10255.5
|
L
 -100.0%
H
1.1
169920
|
| BioAffinity Tech Inc |
|
5.2
|
0.8
|
L
 -1.2%
H
0.8
0.9
|
L
 -1.2%
H
0.8
0.9
|
L
 -49.7%
H
0.8
2.2
|
L
 -82.5%
H
0.8
5.1
|
L
 -92.3%
H
0.7
13.5
|
L
 -98.4%
H
0.7
108.6
|
L
H
0.7
466.5
|
L
H
0.7
466.5
|
| Bluejay Diagnostics Inc |
|
3.0
|
2.9
|
L
 -11.5%
H
2.7
3.4
|
L
 -34.3%
H
2.7
4.3
|
L
 51.8%
H
1.9
7
|
L
 48.0%
H
1.6
7
|
L
 -53.0%
H
1.6
16.7
|
L
 -100.0%
H
1.6
22368
|
L
H
1.6
200000
|
L
H
1.6
200000
|
| Biolife Soln Inc |
|
1,400.7
|
28.7
|
L
 4.3%
H
27.3
29.8
|
L
 10.1%
H
24.8
29.8
|
L
 19.3%
H
23.7
29.8
|
L
 45.9%
H
17.9
29.8
|
L
 33.5%
H
17.9
29.8
|
L
 26.2%
H
8.9
29.8
|
L
 -35.7%
H
8.9
60.7
|
L
 1680.7%
H
1.4
60.7
|
| Biomerica Inc |
|
5.4
|
1.8
|
L
H
1.7
1.8
|
L
 -2.2%
H
1.7
2.1
|
L
 -29.2%
H
1.7
2.5
|
L
 -17.1%
H
1.7
2.5
|
L
 -45.3%
H
1.7
4.6
|
L
 28.7%
H
0.2
4.9
|
L
 -55.5%
H
0.2
7.4
|
L
 20.7%
H
0.2
23.4
|
| Bruker Corp |
|
9,272.1
|
60.9
|
L
 0.0%
H
59.8
61.2
|
L
 6.5%
H
54.9
62.4
|
L
 29.8%
H
46.4
64.5
|
L
 72.4%
H
33.1
64.5
|
L
 44.4%
H
28.5
64.5
|
L
 -16.9%
H
28.5
94.9
|
L
 -18.3%
H
28.5
94.9
|
L
 166.0%
H
19.6
94.9
|
| BioRestorative Therapies Inc |
|
9.4
|
0.4
|
L
 -5.1%
H
0.4
0.4
|
L
 -9.8%
H
0.4
0.4
|
L
 48%
H
0.3
0.7
|
L
 23.3%
H
0.2
0.7
|
L
 -77.8%
H
0.2
1.9
|
L
 -94.3%
H
0.2
7.0
|
L
 -98.7%
H
0.2
32
|
L
 -100.0%
H
0.2
20040
|
| Biosig Tech Inc |
|
83.4
|
0.8
|
L
 8.1%
H
0.7
0.8
|
L
 -13.0%
H
0.7
0.9
|
L
 -43.3%
H
0.7
1.6
|
L
 -29.8%
H
0.7
1.6
|
L
 -90.6%
H
0.7
14.1
|
L
 -31.0%
H
0.1
14.1
|
L
 -77.8%
H
0.1
14.1
|
L
 -79.9%
H
0.1
14.1
|
| Bioventus Inc (Class A) |
|
662.6
|
9.8
|
L
 0.5%
H
9.4
9.9
|
L
 12.3%
H
8.6
9.9
|
L
 8.4%
H
7.8
9.9
|
L
 5.6%
H
7.8
11.3
|
L
 46.9%
H
5.8
11.3
|
L
 251.8%
H
2.7
14.4
|
L
 -48.0%
H
0.8
19.9
|
L
H
0.8
19.9
|
| Brainsway Ltd (ADR) |
|
581.1
|
14.5
|
L
 -0.4%
H
14.3
14.9
|
L
 -2.8%
H
13.9
15
|
L
 -8.9%
H
13.8
16.0
|
L
 7.3%
H
12.0
17.4
|
L
 341.5%
H
2.8
17.4
|
L
 2396.6%
H
0.5
17.4
|
L
 465.6%
H
0.3
17.4
|
L
H
0.3
17.4
|
| Cardio Diagnostics Holdings Inc |
|
5.9
|
2.0
|
L
 -0.5%
H
2.0
2.1
|
L
 1.5%
H
1.9
2.2
|
L
 13.6%
H
1.7
2.6
|
L
 6.9%
H
1.3
2.6
|
L
 -39.1%
H
1.0
7.9
|
L
 -94.4%
H
1.0
106.8
|
L
H
1.0
307.5
|
L
H
1.0
307.5
|
| Caredx Inc |
|
1,488.8
|
28.8
|
L
 3.5%
H
27.8
29.1
|
L
 10.1%
H
24.5
29.1
|
L
 33.8%
H
21.3
29.1
|
L
 65.0%
H
15.6
29.1
|
L
 49.4%
H
11.0
29.1
|
L
 243.1%
H
4.8
34.8
|
L
 -68.9%
H
4.8
96.9
|
L
 506.7%
H
0.8
99.8
|
| Celcuity Inc |
|
4,874.2
|
100.0
|
L
 4.2%
H
95
101.2
|
L
 13.9%
H
87.0
101.3
|
L
 -25.6%
H
82.6
138.3
|
L
 -12.9%
H
82.6
151.0
|
L
 732.2%
H
11.7
151.0
|
L
 720.6%
H
7.6
151.0
|
L
 235.0%
H
4.8
151.0
|
L
H
4.0
151.0
|
| Creative Medical Tech Holdings Inc |
|
4.4
|
1.2
|
L
 -40%
H
1.1
1.6
|
L
 -46.2%
H
1.1
2.3
|
L
 -48.7%
H
1.1
2.5
|
L
 -39.4%
H
1.1
2.5
|
L
 -57.0%
H
1.1
6.3
|
L
 -73.9%
H
1.1
10.3
|
L
 -99.3%
H
1.1
200
|
L
 -100.0%
H
1.1
525000
|
| Cerus Corp |
|
585.1
|
2.9
|
L
 2.1%
H
2.8
3
|
L
 8.2%
H
2.5
3
|
L
 7.0%
H
2.4
3.1
|
L
 59.6%
H
1.7
3.2
|
L
 114.7%
H
1.2
3.2
|
L
 23.7%
H
1.1
3.2
|
L
 -50%
H
1.1
8.1
|
L
 -51.6%
H
1.1
8.9
|
| Check-Cap Ltd |
|
8.4
|
1.1
|
L
 -1.8%
H
1.1
1.1
|
L
 -23.8%
H
1.1
1.5
|
L
 -36.6%
H
1.1
1.8
|
L
 -33.5%
H
1.1
2.2
|
L
 43.4%
H
0.6
3.9
|
L
 -61.3%
H
0.6
4.6
|
L
 -96.5%
H
0.6
31.6
|
L
 -99.5%
H
0.6
820.8
|
| CollPlant biotech Ltd - Ordinary Shares New |
|
4.8
|
0.3
|
L
 -2.9%
H
0.3
0.4
|
L
 -2.9%
H
0.3
0.4
|
L
 -21.4%
H
0.3
0.5
|
L
 -50%
H
0.3
0.7
|
L
 -76.1%
H
0.3
3.2
|
L
 -96.0%
H
0.3
8.3
|
L
 -98.3%
H
0.3
23
|
L
 -98.2%
H
0.3
24.3
|
| ClearPoint Neuro Inc |
|
554.2
|
18.5
|
L
 2.9%
H
17.1
18.6
|
L
 4%
H
16.3
19.2
|
L
 56.4%
H
11.2
19.2
|
L
 96.8%
H
8.3
19.2
|
L
 53.7%
H
8.3
30.1
|
L
 177.9%
H
4.1
30.1
|
L
 -8.8%
H
4.1
30.1
|
L
 131%
H
1.3
31.3
|
| Cardiff Oncology Inc |
|
85.5
|
1.3
|
L
 3.3%
H
1.2
1.3
|
L
 3.3%
H
1.2
1.4
|
L
 -35.6%
H
1.2
2.0
|
L
 -25.2%
H
1.2
2
|
L
 -60.4%
H
1.2
4.6
|
L
 -17.2%
H
0.9
6.4
|
L
 -83.7%
H
0.9
8.6
|
L
 -99.6%
H
0.7
430.6
|
| Castle Biosciences Inc |
|
737.0
|
24.3
|
L
 6.1%
H
22.7
24.3
|
L
 15.1%
H
20.6
24.3
|
L
 23.4%
H
19.5
24.3
|
L
 -1.6%
H
17.7
26.7
|
L
 23.0%
H
14.6
44.3
|
L
 89.7%
H
12.1
44.3
|
L
 -66.9%
H
9.3
78.9
|
L
H
9.3
107.7
|
| Cytek BioSciences Inc |
|
578.6
|
4.5
|
L
 0.2%
H
4.4
4.6
|
L
 18.8%
H
3.8
4.6
|
L
 12.9%
H
3.7
4.6
|
L
 -2.2%
H
3.3
5.0
|
L
 26.2%
H
3.1
6.2
|
L
 -44%
H
2.4
9.9
|
L
H
2.4
28.7
|
L
H
2.4
28.7
|
| Cytosorbents Corp |
|
22.6
|
0.4
|
L
 -21.7%
H
0.4
0.5
|
L
 -18.2%
H
0.4
0.5
|
L
 -21.7%
H
0.4
0.6
|
L
 -40%
H
0.4
0.7
|
L
 -69.5%
H
0.4
1.3
|
L
 -89.5%
H
0.4
4.3
|
L
 -95.3%
H
0.4
9.8
|
L
 -91.9%
H
0.4
15.0
|
| Citius Pharma Inc |
|
14.8
|
0.5
|
L
H
0.5
0.6
|
L
 -1.8%
H
0.5
0.6
|
L
 -22.9%
H
0.5
0.7
|
L
 -21.7%
H
0.5
1.0
|
L
 -59.4%
H
0.5
2.5
|
L
 -98.4%
H
0.1
34.3
|
L
 -99.4%
H
0.1
96.3
|
L
 -99.8%
H
0.1
450.0
|
| CVRx Inc |
|
155.5
|
5.9
|
L
 11.6%
H
5.3
5.9
|
L
 18.4%
H
4.8
5.9
|
L
 -3.6%
H
4.8
6.2
|
L
 -36.9%
H
4.8
9.8
|
L
 -0.2%
H
4.4
11.3
|
L
 -59.3%
H
4.3
33.1
|
L
H
4.3
33.1
|
L
H
4.3
33.1
|
| Delcath Systems Inc |
|
446.7
|
12.9
|
L
 5.0%
H
12.2
13.0
|
L
 10.7%
H
11.4
13.0
|
L
 19.5%
H
10.2
13.0
|
L
 41.7%
H
8.8
13.0
|
L
 -7.9%
H
8.1
14.2
|
L
 130.7%
H
2.3
18.2
|
L
 11.4%
H
2.3
18.2
|
L
 -100.0%
H
2.3
795025000
|
| Alpha Tau Medical Ltd |
|
982.7
|
10.9
|
L
 -2.6%
H
10.6
11.3
|
L
 11.3%
H
9.5
11.3
|
L
 4.9%
H
8.8
11.3
|
L
 57.7%
H
6.4
11.6
|
L
 260.3%
H
2.9
11.6
|
L
 170.6%
H
1.8
11.6
|
L
H
1.8
20.7
|
L
H
1.8
20.7
|
| DexCom |
|
27,065.1
|
70.1
|
L
 2.2%
H
68.3
70.4
|
L
 -3.2%
H
68.3
71.9
|
L
 -2.6%
H
68.3
78.9
|
L
 6.1%
H
56.7
78.9
|
L
 -17.5%
H
54.1
90.0
|
L
 -43.7%
H
54.1
142
|
L
 -34.8%
H
54.1
164.9
|
L
 262.3%
H
10.7
164.9
|
| Daxor Corp |
|
58.5
|
10.0
|
L
 -2.9%
H
9.9
10.5
|
L
 2.8%
H
9.5
10.7
|
L
 -5.1%
H
9.3
11.2
|
L
 -0.7%
H
8.6
12.3
|
L
 4.2%
H
8.6
14.8
|
L
 3.4%
H
6.6
14.8
|
L
 -8.1%
H
6.6
14.8
|
L
 27.2%
H
3.4
24.1
|
| ElectroCore Inc |
|
65.0
|
7.8
|
L
 9.0%
H
6.9
8.1
|
L
 -6.9%
H
6.9
9.0
|
L
 -12.0%
H
6.9
10.5
|
L
 30.2%
H
5.6
10.5
|
L
 45.2%
H
4.2
10.5
|
L
 102.6%
H
3.8
19.5
|
L
 -69.4%
H
2.9
25.2
|
L
H
2.9
303.8
|
| ChronoScale Corp |
|
3,181.0
|
22.2
|
L
 -1.2%
H
19.9
22.5
|
L
 -4.7%
H
19.8
28.2
|
L
 46.6%
H
14.2
28.2
|
L
 103.9%
H
7.9
28.2
|
L
 522.7%
H
2.9
28.2
|
L
 -92.7%
H
2.7
704.0
|
L
 -98.3%
H
2.7
1316.3
|
L
 -99.9%
H
2.7
22919.6
|
| Embecta Corp |
|
207.1
|
3.5
|
L
 12.2%
H
3.1
3.5
|
L
 12.2%
H
3.0
3.5
|
L
 5.1%
H
3.0
3.5
|
L
 -60.7%
H
2.8
9.9
|
L
 -62.4%
H
2.8
15.6
|
L
 -85.3%
H
2.8
23.8
|
L
H
2.8
63
|
L
H
2.8
63
|
| Establishment Labs Holdings Inc |
|
2,601.1
|
88.4
|
L
 -0.8%
H
87.7
90.5
|
L
 4.2%
H
80
90.5
|
L
 21.7%
H
65.6
90.5
|
L
 47.5%
H
53.2
90.5
|
L
 116.4%
H
33.4
90.5
|
L
 37.5%
H
17
90.5
|
L
 4.1%
H
17
93.8
|
L
H
7.6
93.8
|
| EDAP TMS S.A. (ADR) |
|
191.2
|
5.1
|
L
 1.0%
H
4.8
5.2
|
L
 6.0%
H
4.8
5.2
|
L
 18.3%
H
4.0
5.2
|
L
 35.3%
H
3.1
5.2
|
L
 196.5%
H
1.2
5.2
|
L
 -41.8%
H
1.2
9.5
|
L
 -26.2%
H
1.2
12.7
|
L
 67.2%
H
1.2
12.7
|
| GlucoTrack Inc |
|
2.1
|
0.3
|
L
H
0.3
0.3
|
L
 -10.8%
H
0.3
0.4
|
L
 -45%
H
0.3
0.7
|
L
 -69.7%
H
0.3
1.7
|
L
 -93.7%
H
0.3
14.1
|
L
 -100.0%
H
0.3
5940
|
L
 -100.0%
H
0.3
46800
|
L
 -100.0%
H
0.3
468000
|
| GE HealthCare Tech |
|
29,913.7
|
65.8
|
L
 1.3%
H
65
66.0
|
L
 6.8%
H
60.3
66.0
|
L
 2.5%
H
60.0
66.4
|
L
 -8.1%
H
58.8
76.0
|
L
 -12.2%
H
58.8
89.8
|
L
 -15.5%
H
57.7
94.8
|
L
H
53
94.8
|
L
H
53
94.8
|
| Harvard Bioscience Inc |
|
27.2
|
6.0
|
L
 1.3%
H
6.0
6.1
|
L
 2.9%
H
5.8
6.2
|
L
 6.3%
H
5.7
6.7
|
L
 19.1%
H
4.3
7.5
|
L
 18.0%
H
3.8
9.4
|
L
 -89.8%
H
2.8
60
|
L
 -92.2%
H
2.8
87.5
|
L
 -81.1%
H
2.8
87.5
|
| Heart Test Laboratories Inc |
|
9.7
|
2.9
|
L
 -1.7%
H
2.8
3.2
|
L
 59.8%
H
1.7
3.8
|
L
 52.3%
H
1.6
3.8
|
L
 27.3%
H
1.6
3.8
|
L
 -23.4%
H
1.6
6.5
|
L
 -96.9%
H
1.6
99
|
L
H
1.6
600
|
L
H
1.6
600
|
| Helius Medical Tech Inc (Class A) |
|
101.0
|
1.7
|
L
 16.1%
H
1.5
1.8
|
L
 6.8%
H
1.4
1.8
|
L
 -24.8%
H
1.2
2.3
|
L
 -13.9%
H
1.2
2.4
|
L
 -89.8%
H
1.2
25.5
|
L
 -100.0%
H
1.2
10072.5
|
L
 -100.0%
H
1.2
641250
|
L
 -100.0%
H
1.2
27168750
|
| Hyperfine Inc (Class A) |
|
145.9
|
1.5
|
L
 -13.0%
H
1.5
1.7
|
L
 -8.1%
H
1.4
1.7
|
L
 -11.5%
H
1.4
1.7
|
L
 31.3%
H
1.0
1.9
|
L
 101.4%
H
0.7
2.2
|
L
 -34.4%
H
0.5
3.3
|
L
 -84.8%
H
0.5
16.6
|
L
H
0.5
16.6
|
| Integra Lifesciences Holdings Corp |
|
1,459.5
|
18.8
|
L
 3.7%
H
18
18.9
|
L
 6.7%
H
17.1
18.9
|
L
 23.5%
H
14.8
18.9
|
L
 100%
H
8.9
18.9
|
L
 53.6%
H
8.7
18.9
|
L
 -53.5%
H
8.7
46.8
|
L
 -73.2%
H
8.7
76.7
|
L
 -50.7%
H
8.7
77.4
|
| Icecure Medical Ltd |
|
20.4
|
6.0
|
L
 -15.1%
H
5.6
6.6
|
L
 10.4%
H
5.6
9.4
|
L
 -12.5%
H
2.1
9.5
|
L
 -49.1%
H
2.1
12.3
|
L
 -80.4%
H
2.1
42
|
L
 -82.7%
H
2.1
49.8
|
L
 -98.2%
H
2.1
372
|
L
 -82.8%
H
2.1
480
|
| SeaStar Medical Holding Corp |
|
12.5
|
3.1
|
L
 4.7%
H
3.0
3.3
|
L
H
3.0
3.6
|
L
 -12.9%
H
2.6
3.9
|
L
 11.8%
H
2.6
5.1
|
L
 -92.6%
H
2.1
125
|
L
 -99.8%
H
2.1
4292.3
|
L
 -100.0%
H
2.1
55000
|
L
H
2.1
55000
|
| ICU Medical Inc |
|
3,705.8
|
148.3
|
L
 -0.4%
H
147.7
151.7
|
L
 5.6%
H
135.1
151.7
|
L
 9.9%
H
129.3
151.7
|
L
 16.2%
H
113.4
151.7
|
L
 13.5%
H
107
160.3
|
L
 -16.4%
H
78.4
196.3
|
L
 -29.1%
H
78.4
282
|
L
 39.2%
H
78.4
321.7
|
| Idexx Laboratories |
|
43,504.0
|
551.5
|
L
 -0.6%
H
547.2
561.2
|
L
 -1.9%
H
538.4
570.8
|
L
 -1.0%
H
538.4
581.5
|
L
 -3.8%
H
523.4
605.8
|
L
 4.5%
H
506.9
770.0
|
L
 14.5%
H
356.3
770.0
|
L
 -11.1%
H
317.1
770.0
|
L
 528.4%
H
86.0
770.0
|
| QTREX Quantum |
|
84.7
|
1.6
|
L
 -1.8%
H
1.5
1.7
|
L
 -19.9%
H
1.5
2.3
|
L
 5.9%
H
1.2
3.9
|
L
 215.7%
H
0.3
3.9
|
L
 91.7%
H
0.3
3.9
|
L
 14.2%
H
0.3
3.9
|
L
H
0.3
9.6
|
L
H
0.3
9.6
|
| Intercure Ltd |
|
59.4
|
1.0
|
L
 1.0%
H
1.0
1.1
|
L
 11.8%
H
0.9
1.2
|
L
 14.3%
H
0.9
1.2
|
L
 42.5%
H
0.7
1.2
|
L
 -30.2%
H
0.7
1.8
|
L
 -43.5%
H
0.7
3.7
|
L
 -85.8%
H
0.7
8.8
|
L
H
0.7
19.4
|
| Inogen Inc |
|
187.9
|
6.9
|
L
 2.4%
H
6.7
7.0
|
L
 8.3%
H
6.3
7.0
|
L
 5.5%
H
5.9
7.0
|
L
 6.8%
H
5.9
7.7
|
L
 -3.6%
H
5.3
9.1
|
L
 -37.6%
H
4.1
13.3
|
L
 -89.6%
H
4.1
82.4
|
L
 -85.0%
H
4.1
287.8
|
| Inmode Ltd |
|
840.9
|
14.6
|
L
 -1.2%
H
14.4
14.8
|
L
 9.2%
H
13.2
15.2
|
L
 5.9%
H
13.2
15.2
|
L
 6.4%
H
13.2
15.2
|
L
 4.0%
H
12.7
16.7
|
L
 -58.9%
H
12.7
48.3
|
L
 -69.7%
H
12.7
99.3
|
L
H
6.5
99.3
|
| NAYA Biosciences |
|
4.4
|
2.5
|
L
 97.6%
H
1.8
3.1
|
L
 63.3%
H
1.2
3.1
|
L
 47.6%
H
1.2
3.1
|
L
 -14.9%
H
1.2
3.1
|
L
 -98.0%
H
1.2
169.6
|
L
 -100.0%
H
1.2
10367.9
|
L
 -100.0%
H
1.2
144000
|
L
 -100.0%
H
1.2
709632
|
| IRIDEX Corp |
|
19.7
|
1.1
|
L
 -4.2%
H
1.1
1.2
|
L
H
1.1
1.2
|
L
 8.7%
H
1.0
1.2
|
L
 -16.3%
H
1.0
1.2
|
L
 27.0%
H
0.9
1.7
|
L
 -47.9%
H
0.8
3.7
|
L
 -84.7%
H
0.8
9.5
|
L
 -92.2%
H
0.8
16.6
|
| Iradimed Corp |
|
1,201.1
|
94.0
|
L
 0.1%
H
92.0
95.8
|
L
 1.9%
H
90.2
96
|
L
 1.1%
H
87.9
98.4
|
L
 -4.8%
H
77.0
98.6
|
L
 54.8%
H
55.1
107.9
|
L
 91.0%
H
36.1
107.9
|
L
 230.3%
H
26
107.9
|
L
 354.8%
H
7.9
107.9
|
| iRhythm Tech Inc |
|
3,907.0
|
118.9
|
L
 2.5%
H
114.4
121.9
|
L
 13.6%
H
102.0
121.9
|
L
 3.9%
H
100.9
121.9
|
L
 -3.2%
H
100.9
130.0
|
L
 -22.1%
H
100.9
212
|
L
 22.1%
H
55.9
212
|
L
 76.6%
H
41.7
212
|
L
H
22.2
286.2
|
| Intuitive Surgical |
|
143,329.7
|
404.7
|
L
 1.3%
H
399.3
409.8
|
L
 -0.5%
H
398.9
412.5
|
L
 -7.3%
H
396.7
439.2
|
L
 -13.6%
H
396.7
491.2
|
L
 -24.2%
H
396.7
603.9
|
L
 24.5%
H
254.9
616
|
L
 33.7%
H
180.1
616
|
L
 464.8%
H
67.9
616
|
| Kewaunee Scientific Corp |
|
102.7
|
35.8
|
L
 2.0%
H
35.2
36.4
|
L
 -4.6%
H
33.3
38.1
|
L
 -10.4%
H
33.3
41.2
|
L
 3.0%
H
33.3
41.2
|
L
 -34.6%
H
33.3
60.9
|
L
 127.9%
H
14.6
71.3
|
L
 142.0%
H
12.1
71.3
|
L
 87.6%
H
7.0
71.3
|
| OrthoPediatrics corp |
|
521.4
|
20.3
|
L
 3.5%
H
19.5
20.6
|
L
 7.6%
H
18.1
20.6
|
L
 13.4%
H
16.4
20.6
|
L
 24.2%
H
14.4
20.6
|
L
 -6.8%
H
14.4
23.7
|
L
 -53.0%
H
14.4
46.0
|
L
 -69.7%
H
14.4
73.9
|
L
H
14
73.9
|
| KORU Medical Systems Inc |
|
204.9
|
4.5
|
L
 4.2%
H
4.3
4.6
|
L
 14.4%
H
3.8
4.6
|
L
 6.2%
H
3.8
4.6
|
L
 2.3%
H
3.8
4.7
|
L
 24.6%
H
2.9
6.6
|
L
 23.2%
H
1.9
6.6
|
L
H
1.8
6.6
|
L
 1293.8%
H
0.3
12.8
|
| Standard BioTools Inc |
|
285.8
|
0.7
|
L
 -1.4%
H
0.7
0.8
|
L
 -12.1%
H
0.7
0.9
|
L
 -33.0%
H
0.7
1.3
|
L
 -24.0%
H
0.7
1.3
|
L
 -42.5%
H
0.7
1.7
|
L
 -62.9%
H
0.7
3.2
|
L
 -88.3%
H
0.7
7.5
|
L
 -92.2%
H
0.7
14.9
|
| LivaNova PLC |
|
4,583.1
|
83.4
|
L
 2.9%
H
80.9
84.0
|
L
 6.3%
H
77.7
84.0
|
L
 10.6%
H
71
84.0
|
L
 31.1%
H
56.4
84.0
|
L
 82.2%
H
41.0
84.0
|
L
 69.0%
H
32.5
84.0
|
L
 -3.6%
H
32.5
93.9
|
L
 73.3%
H
32.5
131.5
|
| Lemaitre Vascular Inc |
|
2,185.9
|
95.7
|
L
 1.8%
H
92.9
96.0
|
L
 1.8%
H
88.6
96.0
|
L
 -3.1%
H
88.6
99.7
|
L
 -13.3%
H
88.6
118.0
|
L
 16.1%
H
79
118.0
|
L
 42.0%
H
44.3
118.0
|
L
 51.1%
H
38.3
118.0
|
L
 563.4%
H
13.5
118.0
|
| LENSAR Inc |
|
69.1
|
5.6
|
L
 -8.3%
H
5.6
6.1
|
L
 -1.9%
H
5.6
6.2
|
L
 -6.9%
H
5.5
6.5
|
L
 2.0%
H
5.1
6.5
|
L
 -55.1%
H
5.1
13.5
|
L
 47.8%
H
1.8
17.3
|
L
 -28.4%
H
1.8
17.3
|
L
H
1.8
17.3
|
| Lantheus Holdings Inc |
|
7,148.6
|
109.8
|
L
 0.7%
H
108.5
111.5
|
L
 5.7%
H
103.5
111.5
|
L
 9.7%
H
95
111.5
|
L
 43.8%
H
72.4
111.5
|
L
 36.0%
H
47.3
111.5
|
L
 27.0%
H
47.3
126.9
|
L
 303.7%
H
22.2
126.9
|
L
 3878.3%
H
2.6
126.9
|
| Lucid Diagnostics Inc |
|
206.0
|
1.1
|
L
 3.9%
H
1.0
1.1
|
L
H
1.0
1.1
|
L
 -2.7%
H
1.0
1.1
|
L
 -6.1%
H
0.9
1.4
|
L
 -9.2%
H
0.9
1.6
|
L
 -22.3%
H
0.6
1.8
|
L
H
0.6
13.5
|
L
H
0.6
13.5
|
| Pulmonx Corp |
|
52.8
|
1.3
|
L
H
1.2
1.3
|
L
 -2.3%
H
1.2
1.4
|
L
 -20.4%
H
1.2
1.7
|
L
 0.8%
H
1.1
1.7
|
L
 -51.7%
H
1.1
3.9
|
L
 -90.3%
H
1.1
14.8
|
L
 -97.2%
H
1.1
45.8
|
L
H
1.1
69.5
|
| 908 Devices Inc |
|
332.0
|
8.8
|
L
 -2.2%
H
8.7
9.2
|
L
 -0.8%
H
8.5
9.3
|
L
 10.9%
H
7.6
9.3
|
L
 43%
H
5.7
9.3
|
L
 30.3%
H
5.0
9.3
|
L
 28.9%
H
1.8
12.5
|
L
 -77.8%
H
1.8
41.5
|
L
H
1.8
79.6
|
| Mimedx Grp Inc |
|
585.4
|
3.9
|
L
 3.2%
H
3.8
4.0
|
L
 7.1%
H
3.6
4.0
|
L
 7.1%
H
3.5
4.0
|
L
 -0.3%
H
3.0
4.1
|
L
 -33.8%
H
3.0
8.0
|
L
 -38.1%
H
3.0
10.1
|
L
 -65.1%
H
2.4
16.0
|
L
 -48.1%
H
1.0
18.3
|
| Mesa Laboratories Inc |
|
565.9
|
102.4
|
L
 4.4%
H
96.3
103.4
|
L
 7.7%
H
87.2
103.4
|
L
 -3.5%
H
81.3
114.0
|
L
 25.3%
H
81.3
114.0
|
L
 6.3%
H
55.5
114.0
|
L
 -19.6%
H
55.5
155.1
|
L
 -62.5%
H
55.5
333.4
|
L
 -14.9%
H
55.5
333.4
|
| Merit Medical Systems Inc |
|
4,279.0
|
71.7
|
L
 1.3%
H
71
72.8
|
L
 6.7%
H
66.3
72.8
|
L
 11.2%
H
60.0
72.8
|
L
 3.5%
H
59.7
72.8
|
L
 -22.7%
H
59.7
96.7
|
L
 -12.8%
H
59.7
111.5
|
L
 11.3%
H
50.5
111.5
|
L
 282.8%
H
18.2
111.5
|
| Modular Medical Inc |
|
26.7
|
4.9
|
L
 19.9%
H
4.0
5.8
|
L
 -4.1%
H
3.9
5.8
|
L
 0.8%
H
3.9
5.8
|
L
 -5.4%
H
3.1
6.2
|
L
 -74.6%
H
3.1
30
|
L
 -83.5%
H
3.1
79.5
|
L
 -99.1%
H
3.1
540
|
L
 -79.7%
H
3.1
585.0
|
| Myriad Genetics Inc |
|
555.4
|
5.9
|
L
 8.3%
H
5.3
5.9
|
L
 29.5%
H
4.4
5.9
|
L
 52.7%
H
3.8
5.9
|
L
 27.3%
H
3.5
5.9
|
L
 10.3%
H
3.5
8.6
|
L
 -74.2%
H
3.5
29.3
|
L
 -82.0%
H
3.5
37.0
|
L
 -80.4%
H
3.5
50.4
|
| MDxHealth SA (ADR) |
|
-
|
0.4
|
L
 -6.5%
H
0.4
0.5
|
L
 -20.4%
H
0.4
0.6
|
L
 -45.6%
H
0.4
0.8
|
L
 -84.1%
H
0.4
2.8
|
L
 -80.3%
H
0.4
5.3
|
L
 -86.7%
H
0.4
5.3
|
L
H
0.4
13.2
|
L
H
0.4
13.2
|
| ENvue Medical Inc |
|
3.5
|
0.6
|
L
 1.8%
H
0.6
0.6
|
L
 -13.4%
H
0.6
0.8
|
L
 -37.6%
H
0.6
1.0
|
L
 -74.8%
H
0.6
2.7
|
L
 -93.3%
H
0.6
17.4
|
L
 -99.8%
H
0.6
465.3
|
L
 -100.0%
H
0.6
9218
|
L
 -100.0%
H
0.6
18700
|
| ENDRA Life Sciences Inc |
|
9.2
|
5.0
|
L
 16.1%
H
4.5
5.3
|
L
 4.8%
H
3.6
6.7
|
L
 -4.0%
H
3.6
6.7
|
L
 8.7%
H
3.6
6.7
|
L
 42.6%
H
3.0
12.0
|
L
 -93.7%
H
0.0
139.5
|
L
 -99.8%
H
0.0
2350
|
L
H
0.0
5880
|
| Neogen Corp |
|
2,085.3
|
9.6
|
L
 0.7%
H
9.3
9.7
|
L
 2.9%
H
8.8
9.7
|
L
 4.8%
H
8.6
9.7
|
L
 4.7%
H
8.2
10.8
|
L
 100%
H
4.6
11.4
|
L
 -55.2%
H
3.9
24.1
|
L
 -79.2%
H
3.9
47.8
|
L
 -51.0%
H
3.9
48.9
|
| Nephros Inc |
|
39.2
|
3.6
|
L
 10.4%
H
3.2
3.6
|
L
 14.6%
H
3.2
3.6
|
L
 0.8%
H
3.1
3.8
|
L
 22.8%
H
2.7
3.8
|
L
 -14.9%
H
2.7
6.4
|
L
 124.2%
H
1.3
6.4
|
L
 -61.3%
H
0.9
11.7
|
L
 48.6%
H
0.9
11.7
|
| NeuroOne Medical Tech Corp |
|
29.1
|
3.3
|
L
 4.4%
H
3.2
3.4
|
L
 1.5%
H
3.1
3.4
|
L
 -13.7%
H
3.1
4.1
|
L
 -26.8%
H
3.1
5.4
|
L
 -23.7%
H
3.1
7.0
|
L
 -44.9%
H
2.4
12
|
L
 -91.8%
H
2.4
42
|
L
H
2.4
180
|
| Nano X Imaging Ltd |
|
75.9
|
1.1
|
L
 23.9%
H
0.8
1.3
|
L
 -34.7%
H
0.7
1.7
|
L
 -45.0%
H
0.7
2.1
|
L
 -52.0%
H
0.7
3.1
|
L
 -79.7%
H
0.7
5.7
|
L
 -92.8%
H
0.7
16.5
|
L
 -96.6%
H
0.7
34.5
|
L
H
0.7
94.8
|
| NeuroPace Inc |
|
561.5
|
16.5
|
L
 0.7%
H
16.2
17.2
|
L
 5.4%
H
15.2
17.2
|
L
 -1.3%
H
14.9
17.7
|
L
 20.6%
H
12.5
19.6
|
L
 50.6%
H
7.6
19.6
|
L
 265.2%
H
3.9
19.6
|
L
 -29.1%
H
1.2
25.3
|
L
H
1.2
27.4
|
| InspireMD Inc |
|
33.7
|
0.7
|
L
 9.1%
H
0.6
0.7
|
L
 1.4%
H
0.6
0.8
|
L
 -24.2%
H
0.6
1.0
|
L
 -58.4%
H
0.6
1.7
|
L
 -68.1%
H
0.6
2.9
|
L
 -68.6%
H
0.6
3.9
|
L
 -86.8%
H
0.6
6.8
|
L
 -100.0%
H
0.6
275625
|
| Nortech Systems Inc |
|
45.9
|
16.4
|
L
 -1.5%
H
16
16.8
|
L
 -6.1%
H
15.7
17.6
|
L
 27.1%
H
12.7
18.0
|
L
 66.4%
H
11
18.0
|
L
 91.6%
H
6.5
18.0
|
L
 76.9%
H
6.5
19.2
|
L
 122.8%
H
6.5
19.6
|
L
 333.2%
H
1.7
19.6
|
| Natera Inc |
|
37,509.5
|
261.9
|
L
 0.5%
H
257.1
270.4
|
L
 13.2%
H
219.5
271.5
|
L
 30.4%
H
196.4
271.5
|
L
 33.5%
H
181
271.5
|
L
 55.7%
H
131.8
271.5
|
L
 425.4%
H
36.9
271.5
|
L
 127.5%
H
26.1
271.5
|
L
 1844.4%
H
7.4
271.5
|
| Nutriband Inc |
|
37.2
|
3.1
|
L
 1.0%
H
2.9
3.1
|
L
 5.5%
H
2.9
3.3
|
L
 -12.1%
H
2.9
3.7
|
L
 -20.5%
H
2.9
4.3
|
L
 -60.9%
H
2.9
11.7
|
L
 50%
H
1.5
11.8
|
L
 -72.5%
H
1.5
12.9
|
L
H
0.9
43.5
|
| Nuwellis Inc |
|
1.2
|
3.3
|
L
 -0.3%
H
3.1
3.8
|
L
 2438.5%
H
0.1
3.8
|
L
 262.6%
H
0.1
3.8
|
L
 200%
H
0.1
3.8
|
L
 -69.6%
H
0.1
26.0
|
L
 -99.9%
H
0.1
4189.5
|
L
 -100.0%
H
0.1
779100
|
L
 -100.0%
H
0.1
10000000000
|
| NovoCure Ltd |
|
1,787.1
|
15.4
|
L
 2.5%
H
14.9
15.6
|
L
 8.1%
H
13.4
15.6
|
L
 -15.5%
H
13.4
18.4
|
L
 31.2%
H
10.1
18.9
|
L
 -9.8%
H
9.8
18.9
|
L
 -62.8%
H
9.8
42.7
|
L
 -93.0%
H
9.8
226.1
|
L
 45.4%
H
6.0
232.8
|
| enVVeno Medical Corp |
|
7.2
|
10.8
|
L
 -1.9%
H
10.6
11.8
|
L
 8.4%
H
9.8
11.8
|
L
 -3.6%
H
9.7
11.8
|
L
 3.1%
H
9.0
13.4
|
L
 -92.6%
H
8.7
196.7
|
L
 -89.0%
H
8.7
244.0
|
L
 -95.4%
H
8.7
398.3
|
L
H
8.7
4935
|
| Nexalin Tech Inc |
|
7.8
|
0.4
|
L
 5.9%
H
0.4
0.4
|
L
 -2.7%
H
0.3
0.4
|
L
 -25%
H
0.3
0.6
|
L
 -5.3%
H
0.3
0.6
|
L
 -64%
H
0.3
2
|
L
 -60%
H
0.3
4.5
|
L
H
0.3
4.5
|
L
H
0.3
4.5
|
| Nyxoah SA |
|
166.9
|
1.7
|
L
 2.5%
H
1.6
1.7
|
L
 4.4%
H
1.5
1.7
|
L
 -38.2%
H
1.3
3.1
|
L
 -46.0%
H
1.3
3.6
|
L
 -78.3%
H
1.3
8.6
|
L
 -79.5%
H
1.3
20
|
L
 -93.8%
H
1.3
37
|
L
H
1.3
37
|
| Nanobiotix (ADR) |
|
1,827.8
|
36.0
|
L
 4.5%
H
34.7
36.5
|
L
 -0.8%
H
33.1
38
|
L
 -11.8%
H
31.7
41.2
|
L
 14.9%
H
29
57.1
|
L
 660.9%
H
4.5
57.1
|
L
 569.0%
H
2.8
57.1
|
L
 149.9%
H
1.8
57.1
|
L
H
1.8
57.1
|
| Orchestra BioMed Holdings Inc |
|
253.9
|
4.2
|
L
 8.7%
H
3.9
4.3
|
L
 6.3%
H
3.9
4.3
|
L
 6.8%
H
3.8
4.3
|
L
 -5.6%
H
3.7
4.7
|
L
 42.3%
H
2.2
5.4
|
L
 -43.8%
H
2.2
11.7
|
L
 -57.6%
H
2.2
23.4
|
L
H
2.2
23.4
|
| Orthofix Medical Inc |
|
395.3
|
9.8
|
L
 5.1%
H
9.3
9.9
|
L
 3.5%
H
8.9
9.9
|
L
 0.1%
H
8.9
10.6
|
L
 -17.1%
H
8.9
13.0
|
L
 -11.4%
H
8.9
17.0
|
L
 -45.8%
H
8.9
21.6
|
L
 -76.6%
H
8.9
43.3
|
L
 -77.1%
H
8.9
74.4
|
| Outset Medical Inc |
|
84.9
|
4.6
|
L
 -0.2%
H
4.5
5.1
|
L
 -9.3%
H
4.5
5.2
|
L
 4.1%
H
4
5.4
|
L
 30.1%
H
3.3
5.4
|
L
 -77.3%
H
3
21.4
|
L
 -98.6%
H
0.5
337.1
|
L
 -99.4%
H
0.5
905.0
|
L
H
0.5
1004.4
|
| Organogenesis Holdings Inc (Class A) |
|
312.7
|
2.4
|
L
H
2.4
2.5
|
L
 -0.4%
H
2.3
2.5
|
L
 -8.7%
H
2.2
2.7
|
L
 0.4%
H
2.0
2.8
|
L
 -32.7%
H
2.0
7.1
|
L
 -28.1%
H
2.0
7.1
|
L
 -85.7%
H
1.8
17.5
|
L
H
1.8
310.9
|
| Orasure Tech Inc |
|
307.1
|
4.5
|
L
 1.1%
H
4.4
4.5
|
L
 4.9%
H
4.1
4.5
|
L
 13.2%
H
3.9
4.6
|
L
 45.3%
H
2.8
4.6
|
L
 47.7%
H
2.1
4.6
|
L
 -10.6%
H
2.1
8.5
|
L
 -53.3%
H
2.1
13.6
|
L
 -32.5%
H
2.1
23.0
|
| Pacific Biosciences of California Inc |
|
512.5
|
1.7
|
L
 3.1%
H
1.6
1.7
|
L
 17.9%
H
1.3
1.7
|
L
 31.0%
H
1.3
1.8
|
L
 22.2%
H
1.1
1.8
|
L
 27.9%
H
1.1
2.7
|
L
 -87.0%
H
0.9
14.6
|
L
 -95.1%
H
0.9
36.4
|
L
 -79.7%
H
0.9
53.7
|
| PAVmed Inc |
|
36.2
|
5.1
|
L
 16.1%
H
4.4
5.1
|
L
 -2.1%
H
4.3
5.7
|
L
 -17.8%
H
3.9
6.5
|
L
 -43.5%
H
3.9
10.2
|
L
 -72.8%
H
3.9
28.4
|
L
 -97.0%
H
3.9
270
|
L
 -99.8%
H
3.9
4365
|
L
H
3.9
6858
|
| Pro-Dex Inc (co) |
|
196.3
|
61.5
|
L
 -5.9%
H
59.0
67.8
|
L
 -4.5%
H
59.0
67.8
|
L
 -5.7%
H
59.0
69.0
|
L
 24.7%
H
43.3
69.0
|
L
 42.6%
H
23.5
69.0
|
L
 228.4%
H
14.5
70.3
|
L
 104.9%
H
12.4
70.3
|
L
 1112.4%
H
3.8
70.3
|
| Pulse Biosciences Inc |
|
1,969.0
|
28.5
|
L
 3.5%
H
26.9
31
|
L
 11.1%
H
25.2
31
|
L
 9.4%
H
23.6
31
|
L
 32.3%
H
17.8
31
|
L
 91.1%
H
12.6
31
|
L
 358.9%
H
3.8
31
|
L
 58.1%
H
1.2
31
|
L
 526.7%
H
1.2
45.8
|
| Axe Compute Inc |
|
77.5
|
7.2
|
L
 10.7%
H
6.5
7.2
|
L
 0.6%
H
6.3
7.3
|
L
 3.5%
H
5.9
9
|
L
 383.8%
H
1.0
10.9
|
L
 -44.5%
H
1.0
32.1
|
L
 -89.4%
H
1.0
106.8
|
L
 -97.8%
H
1.0
439.8
|
L
 -99.9%
H
1.0
20250
|
| Precision Optics Corp Inc |
|
57.9
|
5.3
|
L
 3.9%
H
5.1
5.4
|
L
 -7.5%
H
5.0
5.8
|
L
 6.4%
H
4.8
6.2
|
L
 25.7%
H
3.6
6.2
|
L
 15.8%
H
3.6
6.2
|
L
 -14.4%
H
3.5
6.9
|
L
H
3.5
7.9
|
L
H
3.5
7.9
|
| Insulet |
|
10,961.1
|
158.3
|
L
 2.9%
H
154.5
160.9
|
L
 8.6%
H
138.8
160.9
|
L
 2.9%
H
138.8
161.4
|
L
 -27.4%
H
138.8
218.0
|
L
 -48.9%
H
138.8
354.9
|
L
 -46.7%
H
125.8
354.9
|
L
 -43.1%
H
125.8
354.9
|
L
 454.5%
H
27.6
354.9
|
| Procept BioRobotics Corp |
|
1,284.1
|
22.6
|
L
 5.0%
H
21.5
22.8
|
L
 3.9%
H
19.9
22.8
|
L
 -17.8%
H
19.9
29.7
|
L
 -10.0%
H
19.9
29.7
|
L
 -61.5%
H
19.4
62.2
|
L
 -33.7%
H
19.4
103.8
|
L
H
15.4
103.8
|
L
H
15.4
103.8
|
| Prenetics Global Ltd (Class A) |
|
320.1
|
18.8
|
L
 -4.7%
H
17.7
20.0
|
L
 -8.2%
H
17.7
20.5
|
L
 5.7%
H
16.9
22.2
|
L
 -11.7%
H
14
22.2
|
L
 109.2%
H
7.2
23.6
|
L
 44.3%
H
2.9
23.6
|
L
H
2.9
131.3
|
L
H
2.9
131.3
|
| Profound Medical Corp |
|
236.2
|
6.5
|
L
 2.0%
H
6.3
6.6
|
L
 -5.4%
H
6.3
6.9
|
L
 -4.0%
H
6.3
7
|
L
 3.2%
H
5.8
7.9
|
L
 5.7%
H
3.8
9.0
|
L
 -47.5%
H
3.8
13.5
|
L
 -64.5%
H
3.1
18.4
|
L
 -36.1%
H
0.0
29.0
|
| QuidelOrtho Corporation |
|
940.4
|
13.8
|
L
 2%
H
13.5
14.2
|
L
 0.9%
H
11.8
14.2
|
L
 15.0%
H
11.8
15.8
|
L
 -11.6%
H
9.9
18
|
L
 -52.0%
H
9.9
35.6
|
L
 -83.5%
H
9.9
89.1
|
L
 -88.4%
H
9.9
180.1
|
L
 -19.3%
H
9.9
306.7
|
| Quanterix Corp |
|
203.5
|
4.3
|
L
 14.9%
H
3.7
4.4
|
L
 27.4%
H
3.2
4.4
|
L
 61.2%
H
2.6
4.4
|
L
 10.8%
H
2.4
4.4
|
L
 -34.3%
H
2.4
8.8
|
L
 -81.1%
H
2.4
29.7
|
L
 -93.0%
H
2.4
66.2
|
L
H
2.4
92.6
|
| AVITA Medical Inc |
|
122.2
|
4.0
|
L
 1.3%
H
3.8
4.0
|
L
 -1%
H
3.7
4.2
|
L
 -6.6%
H
3.7
4.6
|
L
 2.9%
H
3.5
5.9
|
L
 -22.5%
H
3.2
7.1
|
L
 -74.7%
H
3.2
21.7
|
L
 -82.0%
H
3.2
21.9
|
L
 -46.7%
H
3.2
55.4
|
| Rockwell Medical Inc |
|
25.7
|
0.7
|
L
H
0.6
0.7
|
L
 1.6%
H
0.6
0.7
|
L
 -14.5%
H
0.6
0.8
|
L
 -30.9%
H
0.6
1.0
|
L
 -19.8%
H
0.6
2.1
|
L
 -84.3%
H
0.6
6.2
|
L
 -93.5%
H
0.6
10.8
|
L
 -99.2%
H
0.6
98.8
|
| Vyome Holdings Inc |
|
15.2
|
2.2
|
L
 2.4%
H
2.1
2.2
|
L
 -0.5%
H
2.1
2.4
|
L
 -6.5%
H
2.1
2.5
|
L
 -1.8%
H
1.8
2.5
|
L
 -9.2%
H
1.8
12.9
|
L
 -97.9%
H
0.3
96.3
|
L
 -100.0%
H
0.3
23345
|
L
H
0.3
1381560
|
| Rewalk Robotics Ltd |
|
432.8
|
7.2
|
L
 3.9%
H
6.9
7.2
|
L
 4.2%
H
6.8
7.2
|
L
 3.2%
H
6.2
8
|
L
 14.3%
H
6
8
|
L
 1141.4%
H
0.4
8
|
L
 74.8%
H
0.4
9.1
|
L
 -42.9%
H
0.4
19.5
|
L
 -99.4%
H
0.4
1373.8
|
| Sanmina Corp |
|
12,678.5
|
236.6
|
L
 -6.7%
H
233.2
248.3
|
L
 -2.1%
H
233.2
260.2
|
L
 -9.0%
H
229.1
288.7
|
L
 80.6%
H
122.2
288.7
|
L
 143.8%
H
95.5
288.7
|
L
 313.2%
H
43.4
288.7
|
L
 510.5%
H
35.1
288.7
|
L
 797.7%
H
18.3
288.7
|
| Sight Sciences Inc |
|
309.6
|
5.7
|
L
 4.2%
H
5.4
5.7
|
L
 7.8%
H
5.0
5.9
|
L
 14.0%
H
4.2
5.9
|
L
 42.3%
H
3.4
5.9
|
L
 33.9%
H
3.1
9.2
|
L
 -30.2%
H
1.0
9.3
|
L
H
1.0
42.6
|
L
H
1.0
42.6
|
| Sotera Health Co |
|
4,956.2
|
17.4
|
L
 1.6%
H
17.1
17.4
|
L
 9.9%
H
15.6
17.4
|
L
 8.9%
H
14.8
17.4
|
L
 28.4%
H
13.1
17.4
|
L
 53.0%
H
10.9
19.9
|
L
 -5.6%
H
9.5
19.9
|
L
 -29.7%
H
5.8
27.4
|
L
H
5.8
30.4
|
| SI-BONE Inc |
|
768.6
|
17.3
|
L
 3.4%
H
16.8
17.5
|
L
 9.4%
H
15.6
17.5
|
L
 18.1%
H
13.4
17.5
|
L
 35.0%
H
11.5
17.5
|
L
 -4.2%
H
11.5
21.9
|
L
 -37.7%
H
11.5
28.6
|
L
 -48.8%
H
11.1
34.0
|
L
H
7.2
37.2
|
| SINTX Tech Inc |
|
12.2
|
1.9
|
L
 3.2%
H
1.8
2.0
|
L
 -9%
H
1.8
2.1
|
L
 -21.0%
H
1.8
2.4
|
L
 -20.7%
H
1.8
3
|
L
 -39.2%
H
1.8
6.8
|
L
 -99.2%
H
0.1
364
|
L
 -100.0%
H
0.1
41100
|
L
 -100.0%
H
0.1
11664000
|
| Beauty Health Co (Class A) |
|
85.5
|
0.7
|
L
 3.1%
H
0.6
0.7
|
L
H
0.6
0.7
|
L
 -23.3%
H
0.6
0.9
|
L
 -26.7%
H
0.6
1
|
L
 -66.0%
H
0.6
2.7
|
L
 -91.7%
H
0.6
9.0
|
L
 -96.3%
H
0.6
30.2
|
L
H
0.6
30.2
|
| Sanara MedTech Inc |
|
218.8
|
23.9
|
L
 3.3%
H
23.1
24.6
|
L
 8.5%
H
20.4
24.6
|
L
 4.1%
H
20.4
24.6
|
L
 32.6%
H
16.2
24.6
|
L
 -15.8%
H
16.1
36.0
|
L
 -39.7%
H
16.1
46.4
|
L
 -33.3%
H
16.1
50.2
|
L
 311.7%
H
2
75
|
| Sensus Healthcare Inc |
|
50.0
|
3.0
|
L
 3.1%
H
2.9
3.0
|
L
 9.0%
H
2.7
3.1
|
L
 -5%
H
2.7
3.3
|
L
 -24.2%
H
2.7
4.6
|
L
 -36.9%
H
2.7
5.9
|
L
 5.9%
H
1.8
9.3
|
L
 -30.9%
H
1.8
15.3
|
L
H
1.8
15.3
|
| Staar Surgical Co. |
|
1,458.3
|
29.3
|
L
 -6.2%
H
29.2
31.3
|
L
 0.6%
H
27.9
31.3
|
L
 -12.2%
H
27.9
33.5
|
L
 57.1%
H
17.5
35.9
|
L
 74.0%
H
15.6
35.9
|
L
 -42.7%
H
13.5
58.8
|
L
 -80.8%
H
13.5
163.1
|
L
 428.7%
H
5.1
163.1
|
| Neuronetics Inc |
|
93.2
|
1.3
|
L
 5.5%
H
1.2
1.4
|
L
 8.9%
H
1.2
1.4
|
L
 9.8%
H
1.2
1.7
|
L
 0.8%
H
1.1
2.5
|
L
 -60.6%
H
0.8
4.9
|
L
 -37.4%
H
0.5
5.9
|
L
 -92.2%
H
0.5
17.2
|
L
H
0.5
39.4
|
| Star Equity Holdings Inc |
|
35.3
|
10.9
|
L
 0.8%
H
10.9
11.0
|
L
 -4.1%
H
10.2
11.4
|
L
 -5.3%
H
10.1
11.9
|
L
 6.4%
H
9
11.9
|
L
 466.8%
H
1.9
12.0
|
L
 60.9%
H
1.7
12.0
|
L
 -36.0%
H
1.7
23.4
|
L
 -95.8%
H
1.7
307.5
|
| SkyAI Inc |
|
46.1
|
1.1
|
L
 14.7%
H
1.0
1.1
|
L
 -7.6%
H
0.9
1.2
|
L
 -40.1%
H
0.9
2.0
|
L
 -34.7%
H
0.9
2.1
|
L
 -80.2%
H
0.9
18.2
|
L
 -100.0%
H
0.0
6204
|
L
H
0.0
23892
|
L
H
0.0
23892
|
| Tactile Systems Tech Inc |
|
683.0
|
30.3
|
L
 8.1%
H
27.9
30.9
|
L
 13.8%
H
25.2
30.9
|
L
 20.8%
H
23.8
30.9
|
L
 13.1%
H
20.5
30.9
|
L
 195.7%
H
9.4
37.8
|
L
 28.8%
H
8.6
37.8
|
L
 -46.9%
H
6.3
57.5
|
L
H
6.3
76.6
|
| TELA Bio Inc |
|
31.8
|
0.7
|
L
 -4.1%
H
0.7
0.8
|
L
 -11.3%
H
0.7
0.9
|
L
 -12.4%
H
0.7
1.0
|
L
 -5.3%
H
0.5
1.3
|
L
 -61.6%
H
0.5
2.2
|
L
 -92.5%
H
0.5
10.8
|
L
 -95.5%
H
0.5
16.3
|
L
H
0.5
23.5
|
| Valion Bio Inc |
|
1.8
|
0.6
|
L
 -3.5%
H
0.5
0.6
|
L
 7.7%
H
0.5
0.6
|
L
 -35.6%
H
0.5
0.9
|
L
 -43.4%
H
0.5
1.4
|
L
 -85.1%
H
0.5
5.6
|
L
 -99.7%
H
0.5
369.8
|
L
H
0.5
11050
|
L
H
0.5
11050
|
| Treace Medical Concepts Inc |
|
289.3
|
4.5
|
L
 0.2%
H
4.4
4.8
|
L
 6.4%
H
3.9
4.8
|
L
 57.6%
H
2.8
4.8
|
L
 248.4%
H
1.2
4.8
|
L
 -20.2%
H
1.2
7.8
|
L
 -82.0%
H
1.2
25.8
|
L
 -85.6%
H
1.2
32.3
|
L
H
1.2
37.2
|
| Transmedics Grp Inc |
|
2,365.3
|
68.4
|
L
 -12.0%
H
66.6
74.5
|
L
 -13.1%
H
66.6
80.3
|
L
 -2.9%
H
64.9
80.7
|
L
 -33.0%
H
60.1
120.9
|
L
 -47.4%
H
60.1
156
|
L
 -14.4%
H
36.4
177.4
|
L
 102.6%
H
10
177.4
|
L
H
10
177.4
|
| Tandem Diabetes Care Inc |
|
1,112.9
|
16.2
|
L
 3.1%
H
15.5
16.5
|
L
 6.1%
H
14.0
16.5
|
L
 11.7%
H
14.0
20.6
|
L
 -30.4%
H
12.3
23.0
|
L
 -15.0%
H
10.0
29.7
|
L
 -37.5%
H
10.0
53.7
|
L
 -83.7%
H
10.0
155.9
|
L
 -77.6%
H
2.1
155.9
|
| Trinity Biotech PLC (ADR) |
|
7.3
|
0.4
|
L
 2.9%
H
0.3
0.4
|
L
 -37.9%
H
0.3
0.6
|
L
 -44.6%
H
0.3
0.8
|
L
 -41.0%
H
0.3
0.8
|
L
 -97.9%
H
0.3
86
|
L
 -99.9%
H
0.3
687.5
|
L
 -100.0%
H
0.3
1906.3
|
L
 -100.0%
H
0.3
8550
|
| Utah Medical Products Inc |
|
235.5
|
74.0
|
L
 10.6%
H
69.0
75.8
|
L
 10.3%
H
64.8
75.8
|
L
 13.4%
H
64.6
75.8
|
L
 18.2%
H
60.9
75.8
|
L
 31.1%
H
53.7
75.8
|
L
 -17.8%
H
51.3
99.5
|
L
 -15.0%
H
51.3
133.9
|
L
 12.3%
H
51.3
133.9
|
| Vivani Medical Inc |
|
103.5
|
1.2
|
L
 5.3%
H
1.2
1.2
|
L
 4.4%
H
1.1
1.3
|
L
 -3.2%
H
1.1
1.3
|
L
 11.1%
H
0.9
1.5
|
L
 -8.4%
H
0.9
1.9
|
L
 -3.2%
H
0.8
7.8
|
L
 -92.2%
H
0.8
15.8
|
L
 -98.6%
H
0.8
109.2
|
| Veracyte Inc |
|
4,826.7
|
60.5
|
L
 3.3%
H
58.1
60.8
|
L
 12.8%
H
52.4
60.8
|
L
 36.8%
H
43.1
60.8
|
L
 84.4%
H
29.5
60.8
|
L
 125.6%
H
22.6
60.8
|
L
 136.1%
H
18.6
60.8
|
L
 44.0%
H
14.9
60.8
|
L
 1097.8%
H
4.8
86.0
|
| Varex Imaging Corp |
|
433.7
|
10.3
|
L
H
9.8
10.5
|
L
 -2.3%
H
9.8
11.0
|
L
 1.2%
H
9.7
11.7
|
L
 -4.6%
H
9.1
12.8
|
L
 20.5%
H
6.8
14.6
|
L
 -54.5%
H
6.8
23.9
|
L
 -63.2%
H
6.8
32.7
|
L
H
6.8
43.8
|
| Vivos Therapeutics Inc |
|
6.3
|
0.5
|
L
 4.7%
H
0.4
0.5
|
L
 -10%
H
0.4
0.5
|
L
 -30.8%
H
0.4
1.4
|
L
 -62.2%
H
0.4
1.5
|
L
 -86.7%
H
0.4
8.0
|
L
 -96.4%
H
0.4
48.8
|
L
 -99.6%
H
0.4
177.3
|
L
H
0.4
360.3
|
| Wrap Tech Inc |
|
65.8
|
1.2
|
L
 11.3%
H
1.0
1.2
|
L
 -4.8%
H
1.0
1.3
|
L
 -16.9%
H
1.0
1.4
|
L
 -19.2%
H
1.0
1.7
|
L
 -21.9%
H
1.0
3.2
|
L
 -11.3%
H
1.0
7.0
|
L
 -85.8%
H
1.0
8.5
|
L
H
1.0
14.4
|
| Beyond Air Inc |
|
6.3
|
0.5
|
L
 4.2%
H
0.5
0.5
|
L
 38.9%
H
0.4
0.5
|
L
 13.6%
H
0.3
0.5
|
L
 -27.5%
H
0.3
0.8
|
L
 -84.7%
H
0.3
4.8
|
L
 -99.4%
H
0.3
96.2
|
L
 -99.7%
H
0.3
328.2
|
L
H
0.3
900
|
| DENTSPLY Sirona Inc |
|
2,205.6
|
11.0
|
L
 2.1%
H
10.7
11.2
|
L
 6.6%
H
10.0
11.2
|
L
 10.2%
H
9.5
11.2
|
L
 -5.6%
H
9.4
13.0
|
L
 -30.5%
H
9.4
17.1
|
L
 -72.0%
H
9.4
41.6
|
L
 -82.8%
H
9.4
67.0
|
L
 -82.0%
H
9.4
69.5
|
| X.T.L. Biopharma Ltd (ADR) |
|
5.6
|
2.4
|
L
 -7.8%
H
2.2
2.7
|
L
 -7.1%
H
2.2
2.8
|
L
 -0.8%
H
2.0
2.8
|
L
 -10.3%
H
2.0
4.9
|
L
 -87.5%
H
2.0
41.1
|
L
 -86.6%
H
2.0
79.8
|
L
 -95.9%
H
2.0
107.0
|
L
 -97.7%
H
2.0
125.6
|
| Jin Medical Intl Ltd |
|
17.7
|
2.3
|
L
 -2.6%
H
2.2
2.3
|
L
 -8.9%
H
2.2
2.5
|
L
 -0.9%
H
2.0
4.5
|
L
 17.7%
H
1.6
4.5
|
L
 -82.7%
H
1.6
17.2
|
L
 -80.2%
H
1.6
509.9
|
L
H
1.6
509.9
|
L
H
1.6
509.9
|
| HeartBeam Inc |
|
37.7
|
0.7
|
L
 6.3%
H
0.6
0.7
|
L
 -10.5%
H
0.6
0.8
|
L
 -23.6%
H
0.6
0.9
|
L
 -37.6%
H
0.6
1.3
|
L
 -51.4%
H
0.5
4
|
L
 -57.0%
H
0.5
4
|
L
 -57.0%
H
0.5
4
|
L
 -57.0%
H
0.5
4
|
| Incannex Healthcare Ltd (ADR) |
|
40.9
|
3.4
|
L
 6.9%
H
3.2
3.5
|
L
 -3.9%
H
3.1
3.6
|
L
 1.8%
H
2.8
4.2
|
L
 0.3%
H
2.5
5
|
L
 -45.5%
H
2.5
49.8
|
L
 -97.9%
H
2.4
160.2
|
L
 -97.9%
H
2.4
160.2
|
L
 -97.9%
H
2.4
160.2
|
| Rewalk Robotics Ltd |
|
20.3
|
7.2
|
L
 3.9%
H
6.9
7.2
|
L
 4.2%
H
6.8
7.2
|
L
 3.2%
H
6.2
8
|
L
 14.3%
H
6
8
|
L
 3.2%
H
4.1
11.0
|
L
 -85.4%
H
4.1
109.2
|
L
 -95.2%
H
4.1
233.5
|
L
 -99.9%
H
4.1
16485
|
| Work Medical Tech Grp Ltd |
|
5.4
|
2.2
|
L
 -0.9%
H
2.1
2.3
|
L
 -30.6%
H
2.1
3.2
|
L
 -80%
H
1.8
18.7
|
L
 -98.1%
H
1.8
733
|
L
 -100%
H
1.8
930000
|
L
H
1.8
8446000
|
L
H
1.8
8446000
|
L
H
1.8
8446000
|
| iTonic Holdings Ordinary |
|
5.3
|
0.3
|
L
H
0.3
0.3
|
L
H
0.3
0.4
|
L
 3.3%
H
0.3
1.2
|
L
 -20.5%
H
0.3
1.2
|
L
 -98.2%
H
0.3
32
|
L
H
0.3
32
|
L
H
0.3
32
|
L
H
0.3
32
|
| Ceribell Inc |
|
758.1
|
20.0
|
L
 1.3%
H
19.6
20.8
|
L
 10.8%
H
17.6
20.8
|
L
 6.3%
H
17.0
20.8
|
L
 8.6%
H
15.8
21.7
|
L
 3.6%
H
10.9
24.3
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
| Anteris Tech Global Corp |
|
943.2
|
9.7
|
L
 -1.9%
H
9.5
10.3
|
L
 -0.9%
H
9.4
10.6
|
L
 6.7%
H
8.4
10.6
|
L
 79.8%
H
5.0
10.6
|
L
 142.3%
H
2.9
10.6
|
L
H
2.3
10.6
|
L
H
2.3
10.6
|
L
H
2.3
10.6
|
| Beta Bionics Inc |
|
749.5
|
16.8
|
L
 5.7%
H
15.6
17.1
|
L
 21.2%
H
13.0
17.1
|
L
 43.5%
H
11.4
17.1
|
L
 46.0%
H
8.8
17.1
|
L
 12.2%
H
8.8
32.7
|
L
H
8.8
32.7
|
L
H
8.8
32.7
|
L
H
8.8
32.7
|
| Kestra Medical Tech Ltd |
|
1,542.8
|
26.4
|
L
 17.1%
H
22.6
27
|
L
 32.6%
H
19.7
27
|
L
 21.1%
H
17.9
27
|
L
 34.3%
H
17.3
27
|
L
 47.7%
H
13.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
| Sanuwave Health Inc |
|
74.0
|
8.6
|
L
 12.8%
H
7.6
8.7
|
L
 -6.5%
H
7.5
9.7
|
L
 -47.1%
H
7.5
17.1
|
L
 -54.3%
H
7.5
21.2
|
L
 -73.9%
H
7.5
46.6
|
L
 -73.4%
H
7.5
46.6
|
L
 -73.4%
H
7.5
46.6
|
L
 -73.4%
H
7.5
46.6
|
| SS Innovations Intl Inc |
|
668.4
|
3.3
|
L
 -7.7%
H
3.3
3.6
|
L
 -3.8%
H
3.2
3.8
|
L
 -10.5%
H
3.2
4.4
|
L
 -32.3%
H
3.2
5.1
|
L
 -48.9%
H
3.1
10
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
| Medline Inc Ordinary Shares |
|
32,868.7
|
38.9
|
L
 2.9%
H
37.5
39.1
|
L
 8.2%
H
34.6
39.1
|
L
 7.5%
H
32.8
39.1
|
L
 -7.9%
H
32.8
49.1
|
L
 -5.2%
H
32.8
50.9
|
L
 -5.2%
H
32.8
50.9
|
L
 -5.2%
H
32.8
50.9
|
L
 -5.2%
H
32.8
50.9
|
| FocalTherics ADR |
|
-
|
5.1
|
L
 1.0%
H
4.8
5.2
|
L
 6.0%
H
4.8
5.2
|
L
 11.8%
H
4.5
5.2
|
L
 11.8%
H
4.5
5.2
|
L
 11.8%
H
4.5
5.2
|
L
 11.8%
H
4.5
5.2
|
L
 11.8%
H
4.5
5.2
|
L
 11.8%
H
4.5
5.2
|